Sanders Morris Harris LLC bought a new position in Counterpoint Quantitative Equity ETF (NYSE:CPAI – Free Report) in the third quarter, according to its most recent 13F filing with the Securities & Exchange Commission. The institutional investor bought 29,507 shares of the company’s stock, valued at approximately $1,544,000. Sanders Morris Harris LLC owned 0.32% of Counterpoint Quantitative Equity ETF at the end of the most recent reporting period.
A number of other institutional investors and hedge funds have also recently added to or reduced their stakes in CPAI. NewEdge Advisors LLC lifted its holdings in shares of Counterpoint Quantitative Equity ETF by 230.6% in the second quarter. NewEdge Advisors LLC now owns 111,269 shares of the company’s stock valued at $5,782,000 after buying an additional 77,610 shares during the period. Counterpoint Mutual Funds LLC raised its position in Counterpoint Quantitative Equity ETF by 5.3% in the first quarter. Counterpoint Mutual Funds LLC now owns 1,549,616 shares of the company’s stock worth $64,758,000 after acquiring an additional 78,500 shares in the last quarter. Royal Bank of Canada lifted its holdings in Counterpoint Quantitative Equity ETF by 122.6% in the 1st quarter. Royal Bank of Canada now owns 44,196 shares of the company’s stock valued at $1,847,000 after acquiring an additional 24,338 shares during the last quarter. Hilltop Holdings Inc. bought a new position in shares of Counterpoint Quantitative Equity ETF during the 1st quarter valued at about $459,000. Finally, Independent Financial Group LLC acquired a new position in shares of Counterpoint Quantitative Equity ETF in the 1st quarter worth approximately $3,154,000.
Counterpoint Quantitative Equity ETF Trading Down 1.6%
Shares of NYSE CPAI traded down $0.84 during midday trading on Wednesday, reaching $52.43. The company’s stock had a trading volume of 58,212 shares, compared to its average volume of 58,205. Counterpoint Quantitative Equity ETF has a one year low of $37.29 and a one year high of $53.96. The company has a market cap of $488.66 million, a price-to-earnings ratio of -62,866.91 and a beta of 1.18. The company has a 50 day moving average price of $52.26 and a 200 day moving average price of $49.75.
About Counterpoint Quantitative Equity ETF
The Counterpoint Quantitative Equity ETF (CPAI) is an exchange-traded fund that mostly invests in total market equity. The fund is actively managed, seeking long-term capital appreciation through a quantitative, model-based approach to select US stocks of any market capitalization. CPAI was launched on Nov 28, 2023 and is issued by Counterpoint.
Read More
- Five stocks we like better than Counterpoint Quantitative Equity ETF
- Tesla Wants to Make Its Own Chips—What Could Go Wrong?
- IREN Limited’s AI Pivot Gains Traction—But Can Its Data Centers Deliver?
- PBF Energy’s Stunning Rally Faces a Critical Test
- Citi Stock Falls Despite Earnings Beat: What Investors Need to Know
Want to see what other hedge funds are holding CPAI? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Counterpoint Quantitative Equity ETF (NYSE:CPAI – Free Report).
Receive News & Ratings for Counterpoint Quantitative Equity ETF Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Counterpoint Quantitative Equity ETF and related companies with MarketBeat.com's FREE daily email newsletter.
